http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11161828-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7bae7cf399c53b51787e575edaf8b820 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-02 |
filingDate | 2019-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_015a09c268791f0abb2cc2c9a4cef4c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df05e5d2980c498fe390a7909fa06e81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d8b1b619ebfbba55da53b1daaf81211 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78bb7774e318858d136201b18d68e2c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43ee35b06bbbf1b2f0e96cc7f6523657 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd7e5c68ef7233831e1cdce3d503a8d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2d64f0da0ad2ea1baee6efff520e9bc |
publicationDate | 2021-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-11161828-B2 |
titleOfInvention | Class of bisquaternary ammonium compound as well as the preparative method and the use thereof |
abstract | A two-quaternary ammonium compound has a structural formula of formula (I). L1 is a C1 to C8 alkylene group; L2 is a C1 to C8 alkylene group; Z1 is nitro group or a halogen or methoxy group; Z2 is nitro group or a halogen or methoxy group; Z3 is nitro group or a halogen or methoxy group; R═H or a C1 to C6 alkyl group; a, b, and c are independently an integer from 0-5; and M is a pharmaceutically acceptable anion, such as a bromine ion, chlorine ion, sulfonate radical, etc. A stereoisomer or mixture of stereoisomers, or a pharmaceutically acceptable salt or solvate or eutectic of the compound of formula (I) forms a composition with a pharmaceutically acceptable carrier, or forms a compounded prescription with other active components, and the composition or compounded prescription may be used in the preparation of a muscle relaxant. |
priorityDate | 2018-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 186.